Gillessen, Silke, Murphy, Laura, James, Nicholas D, Sachdeva, Ashwin, El-Taji, Omar, Abdel-Aty, Hada, Adler, Amanda I, Amos, Claire, Attard, Gerhardt et al (2025) Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol. The Lancet Oncology, 26 (8). pp. 1018-1030. ISSN 1470-2045
Rescigno, Pasquale, Porta, Nuria, Finneran, Laura, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Flohr, Penny, Miranda, Susana, Bertan, Claudia et al (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205 . p. 114103. ISSN 0959-8049
James, Nicholas D., Clarke, Noel W., Cook, Adrian, Ali, Adnan, Hoyle, Alex P., Attard, Gerhardt, Brawley, Christopher D., Chowdhury, Simon, Cross, William R. et al (2022) Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). International Journal of Cancer, 151 (3). pp. 422-434. ISSN 1097-0215